YKYasir Rehman Khattak

Yasir Rehman Khattak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yasir Rehman Khattak has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Mandibular reconstruction with custom-made extended total temporomandibular joint prosthesis after resection of ameloblastoma:A systematic review

    by Muhammad Mushtaq, Amir A. Majeed, Saher Sultan, Rehana Yasmeen, Faryal Sharifullah, Yasir Rehman Khattak, Nasar Shah, Iftikhar Ahmad

    Objectives Ameloblastoma (AB) are aggressive odontogenic tumors, often treated with wide marginal resection and concurrent reconstruction. Extended total temporomandibular joint replacement (eTMJR) prosthesis is a viable treatment option for reconstruction of large defects caused by resection of AB tumors. The objective of this study was to systematically review the utilization and effectiveness of eTMJR prosthesis in treating patients with AB tumors. Methods A detail search in Web of Science, Medline/PubMed, Google Scholar and Embase identified studies reporting AB patients who underwent implantation of eTMJR prosthesis. Studies reporting the use of eTMJR prosthesis in the management of AB tumors were eligible, with no restriction of the study type, language or year of publication and patient’s demographics. Quality assessment of the selected case reports and case series was carried out with the 13 Domains (30 Items) of the CARE checklist, using a scoring scale of “0” (No/ non-adherence), “1” (Yes/ adherence) and “2” (unclear). The completeness of reporting (COR) score was determined as the ratio of “yes” responses to “total” (i.e., yes + no + unclear) responses. Results A total of 27 studies were selected for analysis, including 15 case reports, 06 case series and 06 retrospective cohort studies. These studies presented 41 patients of AB who received eTMJR prosthesis. The patients’ mean age was 37.8 ± 14.9 (range: 14–72, median: 36) years, whereas the mean follow-up period was 19.7 ± 20.3 (range: 1–84, median 12) months. The majority of studies did not document all clinically relevant data regarding patient clinical presentation, surgical procedures, long-term follow-up and post-operative complications. The mean ± SD (range, median) COR score for all case reports/ series was 61.7 ± 23.5 (4.0-100, 64.0) %. Conclusion The use of eTMJR prosthesis in the management of AB tumors has demonstrated promising treatment outcome in case reports/ series. However, large cohort randomized controlled trials are essential to establish their therapeutic efficacy.


  • Laser therapy versus placebo treatment for aphthous ulcers: a systematic review and meta‑analysis

    by Muhammad Imran Ullah, Muhammad Noman Khan, Umer Ullah, Anjum Iqbal, Yasir Rehman Khattak, Iftikhar Ahmad

    Background Aphthous ulcer is a common, painful oral mucosal condition. Laser therapy for these ulcers offers potential benefits in pain relief and mucosal healing. However, its clinical utility remains to be systematically evaluated. Methods A systematic search was performed for randomized controlled trials (RCTs) published between 2020 and 2025, examining the efficacy of laser therapy in patients with aphthous ulcers. Five databases were searched, and data on pain intensity, healing time, and ulcer size were extracted and synthesized. Mean differences (MDs) in tandem with 95% confidence intervals (CIs) were calculated. Results Fourteen RCTs involving 517 participants were included. Laser therapy significantly reduced pain intensity compared to placebo (MD, 3.31; 95% CI, 1.52 to 5.09; p < 0.001) and was associated with a shorter healing time (MD, − 5.86 days; 95% CI, − 9.47 to − 2.26; p < 0.001). Changes in ulcer size were not significant (MD, − 0.87 mm; 95% CI, − 3.53 to 1.78; p = 0.52). Heterogeneity was substantial across all outcomes (I² > 89%), reflecting variability in study designs, patient characteristics, and laser parameters. Conclusions Laser therapy provides significant reductions in pain and healing time in patients with aphthous ulcers, supporting its role as a promising adjunctive treatment. The high heterogeneity among trials underscores the need for standardized protocols and further high-quality research to define optimal treatment parameters.


  • Can growing patients with end-stage TMJ pathology be successfully treated with alloplastic temporomandibular joint reconstruction? – A systematic review

    by Yasir Rehman Khattak, Nabila Ghaffar, Muhammad Assad Gulzar, Sundas Rahim, Faisal Rafique, Zainab Jan, Shaheen Iqbal, Iftikhar Ahmad

    Introduction The use of alloplastic total temporomandibular joint reconstruction (TMJR) in growing patients is controversial, mainly due to immature elements of the craniomaxillofacial skeleton. The aim of this systematic review was to evaluate the use of alloplastic TMJR in growing patients, focusing on the patient’s clinical presentation, surgical and medical history and efficacy of alloplastic TMJR implantation. Materials and methods The literature search strategy was based on the Population, Intervention, Comparator, Outcomes and Study type (PICOS) framework. We searched Pubmed, Google Scholar, Dimension, Web of Science, X-mol, Semantic Scholar and Embase to January 2023, without any restriction on the type of publication reporting alloplastic TMJR in growing patients (age ≤ 18 years for boys and age ≤ 15 years for girls). Results A total of 15 studies (case reports: 09, case series: 02, cohort studies: 04) met the inclusion criteria, documenting 73 patients of growing age from 07 countries. Thirty-eight (~ 52%) cases were female. The mean ± SD (range) age and follow-up of patients in all studies was 13.1 ± 3.2 (0–17) years and 34.3 ± 21.5 (7–96) months, respectively. A total of 22 (30%) patients were implanted with bilateral alloplastic TMJR. Over half of the studies (n = 10) were published in the last 3 years. All patients underwent multiple surgeries prior to implantation of alloplastic TMJR. In extreme cases, patients underwent a total of 17 surgeries. Different types of studies reporting inconsistent variables restricted our ability to perform quality assessment measures for evidence building. Conclusions Clinical experience with alloplastic TMJR in growing patients is limited to cases showing poor prognosis with other types of reconstruction. Nevertheless, studies show promising results for the use of alloplastic TMJR in growing patients, highlighting the need for well-controlled prospective studies with long-term follow-up.


  • Comparison of photodynamic therapy and corticosteroid therapy in management of oral lichen planus: A systematic review of randomized controlled trials

    by Muhammad Assad Gulzar, Neelam Gul, Firas Dost Alvi, Yasir Rehman Khattak, Uzma Saeed Hasan, Muhammad Bilal Haneef, Iftikhar Ahmad


  • Total temporomandibular joint reconstruction prosthesis in hemifacial microsomia: A systematic review

    by H. Arif, R. Ashraf, F. Khan, Y. R. Khattak, H. Nisar, I. Ahmad

    Hypoplastic asymmetry due to hemifacial microsomia (HFM) often represents the most difficult reconstruction in the craniomaxillofacial clinic. Although autogenous grafts are generally used for temporomandibular joint reconstruction (TMJR), the use of TMJR prostheses is not well established. The aim of this review was to identify, collect and analyse the use of extended TMJR (eTMJR) prostheses in patients with HFM, describing clinical features, surgical procedures and postoperative complications. Online searches of all major databases were performed according to PRISMA guidelines. All studies with HFM patients treated with the eTMJR prostheses were included. Descriptive statistics were used for data analysis. A total of 19 studies, including 08 case studies, 06 case series and 05 retrospective cohort studies, met the inclusion criteria, where a total of 42 HFM patients were reported from 18 countries, mostly from the United States (05; 26%). Fifteen of the 42 cases (~36%) were male. The mean ± SD (range) age of patients in all studies was 19.79 ± 5.81 (9‐36) years. The mean ± SD (range) of patient follow‐up was 41.30 ± 35.50 (6‐136) months. A total of 5 (10.6%) patients were implanted with bilateral eTMJR prostheses. The Pruzansky classification was used in 18 (~89.5%) studies, OMENS classification in 01 (~5%) study, whereas no classification was reported in one study. Only 01 (7.1%) study had documented the eTMJR classification for the prosthesis used. In growing patients with or without a history of failed autogenous tissues, TMJR prostheses may provide a viable alternative. Randomized studies with large cohorts are warranted to validate these preliminary results.